On October 14, 2021 KIELTYKA GLADKOWSKI will take part in a webinar organised by CohnReznick, focused on plans for healthcare services investment.
As deal activity in healthcare services reached an all-time high in 2020 and last year, the suddenness of the COVID-19 pandemic prompted investors and healthcare providers to look to the M&A market in record numbers, the organisers of the webinar will discuss the environment, trends and deals (closed and planned to expand existing and explore new platforms).
As providers continue to adjust their business models and the ways they provide care to their patients, Private Equity and M&A statistics offer tea leaves into how they plan to do that. The panelists will therefore provide insights on investment trends, healthcare company value drivers and opportunities for the sector.
More
KIEŁTYKA GŁADKOWSKI KG LEGAL constantly supervises and prepares its lawyers for the specialization in which they provide services for foreign clients. In order to systematize the conceptual grid of very specialized fields of pharma, biology, medicine and life sciences as well as new tech in healthcare KIEŁTYKA GŁADKOWSKI conducts internal consultations to improve the experience of our lawyers specializing in legal assistance for foreign clients from life science and tech sector. As a result of such internal research, KIEŁTYKA GŁADKOWSKI creates and publishes texts on topics related to modern legal problems, but also to explain the basic concepts of specialized life sciences and pharmaceutical fields. In this way, KIEŁTYKA GŁADKOWSKI aims to demonstrate to potential clients within specialized industries that our lawyers are also familiar with specialist terms necessary for a proper understanding of our foreign client’s business and legal needs.
This is
one of those texts. We invite you to read it.
More
Johnson & Johnson case
Thousands of lawsuits have been filed against Johnson & Johnson, a company known for its baby products, in recent years – but the most well-known one involves 22 women who alleged that their ovarian cancers have been caused by the baby powder they had been using. After the appeal, by the end of which the amount of money the company had to pay those women was reduced from 4.7 billion to 2.1 billion, Johnson & Johnson took legal steps to present the case before the Supreme Court. The Supreme Court has decided not to consider their case, however, which resulted in leaving in place the last verdict of the Missouri appeals-court.
The link between the illness and the product
was supposed to be based on the fact that Johnson & Johnson baby powders
contained talc. Talc is oftentimes found in close proximity to asbestos, which
is carcinogenic, and in the past the talc has been contaminated with asbestos.
It is also worth mentioning, that talk on itself is dangerous while inhaled in
large doses but the studies aren’t clear on whether or not it’s carcinogenic on
itself.
Although Johnson & Johnson denies that
their products are dangerous to health, they will no longer be selling the baby
powder containing talc in the US and Canada, focusing instead on the
corn-starch-based alternative.
Polish Regulations
More
AML stands for anti-money laundering, and its main task is to protect the financial system from being used for criminal purposes. Currently, the virtual currency market is one of the fastest growing in the world. Unfortunately, they are often used for illegal purposes. To prevent this, on May 15, 2021 an amendment to the AML Act entered into force.
Act of
March 1, 2018 on counteracting money laundering and financing of terrorism –
Polish regulations
More
In the previous article we wrote about EU 5th AML Directive (2018/843). [1] Currently, after 6 months of passing the 5th AML Directive, the new 6th AML Directive was prepared and passed by the European Parliament and European Council. The new directive (EU 2018/1673) was passed on 23 October 2018 and came into legal effect on the twentieth day following that of its publication in the official journal of the European Union. In respect of the Directive provisions the Member States shall implement the 6AMLD by 3 December 2020 and immediately inform the Commission thereof.
More
